Clinical evaluation of CD62p and CD63, measurement in patients with type 2 diabetes mellitus

黄群,杨香玖,张岩,马红
DOI: https://doi.org/10.3969/j.issn.1001-9057.2001.03.011
2001-01-01
Abstract:Objective To study the clinical evaluation of Platelet α-granule membrane glycoprotein(CD62P) and Platelet lysosomal granule-membrane glycoprotein(CD63) in patients with type2 diabetes mellitus.Methods The expression levels of CD62P and CD63 were measured by FCM in 63 patients with type2 diabetes mellitus (31 cases with microangiopathy,32 without microangiopathy) and in 27 controls.Results The expression levels of CD62P and CD63 in patients with type 2 diabetes mellitus was significantly higher than those in controls (P<0.01). The expression levels of CD62P and CD63 in type 2 diabetes mellitus patients with microangiopathy increased significantly in comparison with patients without microangiopathy (P<0.01).Conclusion The measurement of expression levels of CD62P and CD63 has very important clinical value in early diagnosis of type 2 diabetes mellitus with microangiopathy.
What problem does this paper attempt to address?